Status:
COMPLETED
Polish Survey on the Efficacy of the Hypercholesterolemia Treatment
Lead Sponsor:
AstraZeneca
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the survey is to evaluate the efficacy of treatment of hypercholesterolemia in Polish patients who are currently on lipid- lowering pharmacological therapy . Efficient treatment is defi...
Eligibility Criteria
Inclusion
- Patients on lipid lowering drug treatment
- Lipid lowering drug treatment lasting at least 3 months
- No lipid lowering drug/dose change for a minimum 6 weeks prior to enrolment to the study
Exclusion
- Lack of patient's signed informed consent form
- Lack of the blood sample taken for lipid profile and glucose within 10 days before or after assessment of the patient
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT01243255
Start Date
December 1 2010
End Date
June 1 2011
Last Update
April 4 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.